Stock Titan Deals and strategy
ClearOne (CLRO) details Q2 loss, going concern risk and Cortigent merger plan
ClearOne (CLRO) reported a Q2 loss and highlighted substantial doubt about its ability to continue as a going concern, having ceased revenue-generating operations after selling most assets in October 2025. The company's future hinges on completing a reverse-recapitalization merger with Cortigent and a concurrent $10-$15 million unit offering, both subject to significant conditions. ClearOne is currently funding operations …